News

Devdiscourse7h
WHO Endorses First-Ever RSV Vaccination Guidance to Protect Infants
The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income ...
FDA OKs new COVID-19 vaccine for 65 and older, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
News-Medical.Net on MSN20h
WHO releases first-ever position paper on immunization products to protect infants against RSV
Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
Moderna wins FDA nod for next-gen COVID-19 shot
Moderna (NASDAQ:MRNA) announced on Saturday that the U.S. Food and Drug Administration (FDA) approved its next-gen COVID-19 ...
Baylor College of Medicine4d
For the first time there are safe and effective RSV prevention treatments and they significantly reduce hospitalizations in infants
Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...
Odds of cardiovascular events up for RSV hospitalization versus COVID-19 hospitalization
Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event ...
India Today on MSN2d
Ministry of Health lists key symptoms of respiratory viral illnesses
India's Ministry of Health has released new guidelines to help identify respiratory viral illness symptoms. Early recognition ...
Ohio Department of Health updates COVID-19 dashboard to include flu, RSV
The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...
FDA approves Moderna’s next-generation COVID vaccine for adults 65 or older
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.